All Updates

All Updates

icon
Filter
Partnerships
PathAI partners with ConcertAI for AI-powered histopathology solution
AI Drug Discovery
Apr 25, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
AI Drug Discovery

AI Drug Discovery

Apr 25, 2023

PathAI partners with ConcertAI for AI-powered histopathology solution

Partnerships

  • AI-powered bioinformatics company PathAI has entered into a strategic partnership with AI-powered data solutions provider ConcertAI to develop an AI-powered histopathology solution. The terms and financial details of the partnership have not been disclosed. 

  • The partnership will combine PathAI’s tumor microenvironment panel PathExplore with ConcertAI's Patient360 and RWD360 products to create a new quantitative histopathology and clinical real-world data solution. 

  • The combined solution will be offered to biotech and pharmaceutical companies with the initial focus on a number of cancers including bladder cancer and prostate cancer.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.